Validation of a Laboratory Developed Test (LDT) for the Detection of BRAF V600 Mutations for Therapeutic Decision Making in Melanoma Patients

被引:0
|
作者
Dumur, C. I. [1 ]
Idowu, M. O. [1 ]
Almenara, J. A. [1 ]
Wilkinson, D. S. [1 ]
Ferreira-Gonzalez, A. [1 ]
Powers, C. N. [1 ]
机构
[1] Virginia Commonwealth Univ, Richmond, VA USA
来源
JOURNAL OF MOLECULAR DIAGNOSTICS | 2012年 / 14卷 / 06期
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:721 / 721
页数:1
相关论文
共 50 条
  • [1] Detection of BRAF V600K Mutations in Melanoma: A Comparison of Cobas 4800 BRAF V600 Mutation Test and Laboratory Developed Pyrosequencing Assay
    Wenceslao, S. M.
    Gale, J.
    Vasef, M. A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 700 - 701
  • [2] Melanoma Effectiveness of Vemurafenib on BRAF V600 Mutations
    Voos, Dunja
    AKTUELLE DERMATOLOGIE, 2014, 40 (11) : 434 - 434
  • [3] BRAF V600 mutations and pathological features in Japanese melanoma patients
    Yamazaki, Naoya
    Tanaka, Ryota
    Tsutsumida, Arata
    Namikawa, Kenjiro
    Eguchi, Hironobu
    Omata, Wataru
    Oashi, Kohei
    Ogawa, Toru
    Hayashi, Amiko
    Nakamura, Noriyuki
    Tsuta, Koji
    MELANOMA RESEARCH, 2015, 25 (01) : 9 - 14
  • [4] Detection of BRAF V600 Mutations in Tissue from Various Tumor Sites: Validation of VELA Diagnostics Sentosa SA BRAF V600 PCR Test
    Webber, H.
    Orlando, A.
    Jones, M.
    Ianosie-Irimie, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (06): : 751 - 751
  • [5] Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
    Flaherty, Keith T.
    Infante, Jeffery R.
    Daud, Adil
    Gonzalez, Rene
    Kefford, Richard F.
    Sosman, Jeffrey
    Hamid, Omid
    Schuchter, Lynn
    Cebon, Jonathan
    Ibrahim, Nageatte
    Kudchadkar, Ragini
    Burris, Howard A., III
    Falchook, Gerald
    Algazi, Alain
    Lewis, Karl
    Long, Georgina V.
    Puzanov, Igor
    Lebowitz, Peter
    Singh, Ajay
    Little, Shonda
    Sun, Peng
    Allred, Alicia
    Ouellet, Daniele
    Kim, Kevin B.
    Patel, Kiran
    Weber, Jeffrey
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (18): : 1694 - 1703
  • [6] BRAF V600 mutations and pathological features in Japanese melanoma
    Yamazaki, N.
    Tanaka, R.
    Tsutsumida, A.
    Namikawa, K.
    Eguchi, H.
    Omata, W.
    Oashi, K.
    Tsuta, K.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S874 - S874
  • [7] BRAF V600 mutation detection in melanoma: a comparison of two laboratory testing methods
    O'Brien, Odharnaith
    Lyons, Tomas
    Murphy, Sandra
    Feeley, Linda
    Power, Derek
    Heffron, Cynthia C. B. B.
    JOURNAL OF CLINICAL PATHOLOGY, 2017, 70 (11) : 935 - 940
  • [8] THE COST OF STAGE IV MELANOMA WITH BRAF V600 MUTATIONS IN GREECE
    Carayanni, V
    Gogas, H.
    Bafaloukos, D.
    Boukovinas, I
    Latsou, D.
    Stamuli, E.
    Hatzikou, M.
    VALUE IN HEALTH, 2020, 23 : S462 - S462
  • [9] A Sensitive Peptide Nucleic Acid Probe Assay for Detection of BRAF V600 Mutations in Melanoma
    Chen, Tai-Long
    Chang, John Wen-Cheng
    Hsieh, Jia-Juan
    Cheng, Hsin-Yi
    Chiou, Chiuan-Chian
    CANCER GENOMICS & PROTEOMICS, 2016, 13 (05) : 381 - 386
  • [10] Comparative Methods to Improve the Detection of BRAF V600 Mutations in Highly Pigmented Melanoma Specimens
    Frouin, Eric
    Maudelonde, Thierry
    Senal, Romain
    Larrieux, Marion
    Costes, Valerie
    Godreuil, Sylvain
    Vendrell, Julie A.
    Solassol, Jerome
    PLOS ONE, 2016, 11 (07):